The short answer
GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma albumin fraction by Loren Pickart in 1973. The free peptide has a molecular weight of 340.38 Da; the copper complex is 402.92 Da, the difference being copper bound in place of a displaced proton.
Key facts
- Peptide sequence
- Gly-His-Lys (GHK)
- Free peptide MW
- 340.38 Da (C14H24N6O4)
- Copper complex MW
- 402.92 Da (C14H23CuN6O4+)
- GHK CAS
- 49557-75-7
- GHK-Cu CAS
- 89030-95-5
- PubChem CID (GHK)
- 73587
- PubChem CID (GHK-Cu)
- 71587328
- Isolated
- 1973, human plasma albumin fraction
Two molecules, one name
GHK and GHK-Cu are routinely used interchangeably and they are not the same substance. GHK is the free tripeptide glycyl-histidyl-lysine at 340.38 Da. GHK-Cu is that peptide with a copper(II) ion bound, at 402.92 Da. The 62.54 Da difference is copper's atomic mass minus one proton, because binding displaces a hydrogen. Which one a paper studied matters, and the two are not always distinguished carefully in secondary writing.
Where it came from
Loren Pickart isolated the peptide from the albumin fraction of human plasma in 1973, in the course of work on a different question: why plasma from young donors, added to liver tissue from older donors, caused that tissue to synthesise proteins in a pattern more characteristic of younger tissue. The active fraction turned out to be a tripeptide. It carried the working name liver cell growth factor for a period, and is also indexed as prezatide.
Research material referenced
GHK-Cu 100mg, third-party HPLC tested
Why the copper matters
The histidine imidazole and the terminal amine give GHK a binding site with high affinity for copper(II), and the peptide is generally described as functioning as a copper carrier rather than as a peptide acting alone. That framing has a consequence often missed: much of the reported activity is attributed to delivering copper to enzymes that need it, which makes GHK-Cu as much a metal-delivery system as a signalling peptide. It also anchors the GLOW blend and the four-component KLOW stack.
What the literature reports
Published work describes effects on extracellular matrix biosynthesis, wound-repair models, antioxidant activity via copper delivery, and broad modulation of gene expression. Pickart and Margolina reported in BioMed Research International in 2015 that GHK modulates expression of more than 4,000 human genes, using the Broad Institute Connectivity Map. Nearly all of this is in vitro or animal work.
The declining-with-age observation
Plasma GHK concentrations are reported to fall with age, which is the observation the compound's anti-ageing framing rests on. It is a correlation in an observational measurement, and it does not establish that restoring the concentration reverses anything. A distinction that most writing about GHK-Cu does not make.
Regulatory position
GHK-Cu holds no marketing authorisation from the MHRA, EMA or FDA as a medicine. Copper tripeptide-1 is a recognised cosmetic ingredient name, which means topical products containing it are regulated as cosmetics. A different framework entirely from medicines, and not a route by which research material becomes a licensed product. Material supplied here is for laboratory research only.
Frequently asked questions
What is GHK-Cu's molecular weight?
402.92 Da for the copper complex, 340.38 Da for the free peptide. Sources frequently quote the free peptide's mass while labelling it as the complex.
Is GHK the same as GHK-Cu?
No. GHK is the free tripeptide; GHK-Cu is that peptide with copper(II) bound, displacing a proton. They differ by 62.54 Da.
Who discovered it?
Loren Pickart, in 1973, from the albumin fraction of human plasma while studying why young plasma altered protein synthesis in older liver tissue.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedPickart L & Margolina A, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways. Biomed Res Int 2015 (PMID 26236730)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glycyl-L-histidyl-L-lysine (CID 73587)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · GHK-Cu copper complex (CID 71587328)pubchem.ncbi.nlm.nih.gov
- PubMedPickart L, The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008 (PMID 18644225)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L et al., The Effect of the Human Peptide GHK on Gene Expression. Brain Sci 2017 (PMID 28212278)pubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More GHK-Cu (Copper Peptide) articles
- GHK-Cu Molecular Weight, and Why Published Figures DifferFree GHK is 340.38 Da; the copper complex is 402.92 Da. Multiple PubChem entries exist at different charge states, which is why figures vary between sources.
- GHK vs GHK-Cu: The Free Tripeptide and the Copper ComplexGHK is the free tripeptide at 340.38 Da; GHK-Cu is the copper complex at 402.92 Da. Why the distinction changes what a paper is actually reporting.
- How GHK Binds CopperThe N-terminal amine, backbone nitrogen and histidine imidazole form a copper-binding site. Why this arrangement has high affinity and what it displaces.
- How GHK Was DiscoveredPickart found that plasma from young donors changed protein synthesis in older liver tissue. The active fraction was a tripeptide, isolated in 1973.
- The 4,000 Genes Claim, ExaminedPickart and Margolina reported GHK modulating over 4,000 human genes using the Broad Institute Connectivity Map. What that measures, and what it does not.